Correlation Between Werewolf Therapeutics and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Werewolf Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Anebulo Pharmaceuticals.
Diversification Opportunities for Werewolf Therapeutics and Anebulo Pharmaceuticals
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Werewolf and Anebulo is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 0.95 times more return on investment than Anebulo Pharmaceuticals. However, Werewolf Therapeutics is 1.05 times less risky than Anebulo Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 261.00 in Werewolf Therapeutics on September 22, 2024 and sell it today you would lose (102.00) from holding Werewolf Therapeutics or give up 39.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Werewolf Therapeutics vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Werewolf Therapeutics |
Anebulo Pharmaceuticals |
Werewolf Therapeutics and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Werewolf Therapeutics and Anebulo Pharmaceuticals
The main advantage of trading using opposite Werewolf Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |